COVID-19 vaccine distribution begins

Until a vaccine is widely available, it is important to continue to protect yourself and everyone around you. We have not vaccinated enough people to generate herd immunity.

Last week, the U.S. Food and Drug Administration (FDA) announced an emergency use authorization (EUA) for a COVID-19 vaccine developed by Pfizer. An EUA allows for lifesaving medical products to become available during public health emergencies after a rigorous review of scientific evidence and extensive clinical trials proving that the product’s benefits outweigh its known and potential risks. 

This authorization has allowed the vaccine to begin its initial limited distribution to the highest risk populations, beginning with health care workers whose roles involve high exposure risk and includes older adults living in long-term care facilities. The vaccine will not initially be available to the general public.